Related Experiment Video
Updated: May 29, 2025

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
Published on: March 29, 2024
Nicotine's impact on platelet function: insights into hemostasis mechanisms
Xiayu Wu1,2, Yongjun Liu3, Changhao Zou1,2
1Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Nicotine significantly enhances human platelet function, including aggregation and granule release, by activating PAR4 receptors and downstream signaling pathways. These findings highlight nicotine
Area of Science:
- Pharmacology
- Hematology
- Biochemistry
Background:
- Traditional medicines have utilized tobacco, rich in nicotine, for hemostasis in traumatic injuries.
- Nicotine's pro-aggregatory effects on platelets are known, but its broader impact on platelet function and mechanisms are not fully understood.
Purpose of the Study:
- To comprehensively investigate the functional effects of nicotine on human platelets.
- To elucidate the pharmacological mechanisms underlying nicotine's influence on platelet activation and coagulation.
Main Methods:
- Thromboelastography was used to assess nicotine's impact on platelet function during coagulation.
- Platelet aggregation, granule release, adhesion, spreading, and contraction assays were performed.
- Molecular docking identified potential platelet receptors, followed by inhibitor studies and analysis of downstream signaling pathways (PI3K, AKT, ERK1/2).
Main Results:
- Nicotine fully activated washed human platelets, promoting aggregation, granule release, adhesion, spreading, and contraction.
- Nicotine enhanced intracellular calcium ion concentration ([Ca2+]i) in platelets.
- Nicotine's effects were mediated through the PAR4 receptor, leading to PI3K, AKT, and ERK1/2 phosphorylation and subsequent αIIbβ3 receptor activation.
Conclusions:
- Nicotine activates αIIbβ3 receptors via the PAR4 receptor signaling pathway, significantly enhancing platelet function.
- These findings suggest nicotine's potential as a novel hemostatic agent.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...

